Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab (IIPOP)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
consent form signed
Age >= 18
Carcinomatosis pre operative known or discivered in intraoperative
Patients uin good general condition who may have extent surgery associated to specific inflammatory syndrom of immunotherapy
Patients in good general condition
Patient insured to social care
Inclusion Criteria (intraoperative):
Gastric adenocarcinoma with macroscopic peritoneal carcinomatosis (PC) confirmed by extemporaneous histological examination
CP extension minimal or moderate (peritoneal index ≤ 12).
Resection of the entire macroscopic lesions detectable (primary tumor, lymph nodes and CP). cleaning D2 lymph node (or D1.5).
Presence of metastasis in reach
Previous treatment with a non-humanized monoclonal AC- (mice or rat)
Hypersensitivity to any type of antibody.
History of cancer within 5 years preceding the entry in the trial other than basal cell skin carcinoma or in situ of the cervix,
Patients already included in another clinical trial with experimental molecule
Pregnant, or likely to be or breastfeeding, (Women of childbearing potential should have a pregnancy test (blood) negative 15 days before the date of the surgery) Using of a suitable method of contraception for patients of childbearing age during treatment. adequate contraception Methods includeare: an intrauterine device, hormonal contraception, condom use combined with a spermicide
Persons deprived of liberty or Trust (including curatorship)
Unable to undergo medical test for geographical, social or psychological.
Exclusion Criteria (intraoperative):
Persistent peritoneal lesions visible to the end of the surgery
Resection of the tail of the pancreas or pancreatic break (because no drainage post-op); break pleural (for K cardia)
Presence of metastasis in reach during surgery (except for ovarian metastasis